| Phase 24 trials · 1 missed |
|
Phase 2
|
NCT00917150 |
Mar 2009 → Apr 2014 |
chronic obstructive pulmonary disease |
Otsuka Pharmaceutical Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00874497 |
Mar 2009 → Jul 2015 |
chronic obstructive pulmonary disease |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
Terminated
|
Missed primary
|
|
Phase 2
|
NCT00317356 |
May 2006 → Aug 2007 |
ulcerative colitis |
Otsuka Pharmaceutical Co., Ltd. |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT00317369 |
May 2006 → Jul 2007 |
Crohn disease |
Otsuka Pharmaceutical Co., Ltd. |
Terminated
|
No outcome recorded
|
| Phase 2/31 trial |
|
Phase 2/3
|
NCT00989573 |
Oct 2009 → Aug 2012 |
Crohn disease |
Otsuka Pharmaceutical Co., Ltd. |
Completed
|
No outcome recorded
|
| Phase 33 trials |
|
Phase 3
|
NCT00092508 |
May 2004 → May 2007 |
ulcerative colitis |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00064454 |
May 2003 → Jul 2006 |
ulcerative colitis |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00064441 |
May 2003 → May 2006 |
ulcerative colitis |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
Completed
|
No outcome recorded
|